About this document
Finerenone Efficacy in CKD and T2D Patients by Dandung Ruskar is a document available to read on EtoBox.
This document summarizes the results of two clinical trials evaluating the pharmacokinetics and pharmacodynamics of finerenone in patients with chronic kidney disease and type 2 diabetes. Population pharmacokinetic/pharmacodynamic modeling was used to analyze plasma finerenone concentrations, serum potassium levels, urine albumin-creatinine ratio, estimated glomerular filtration rate, and kidney outcomes. The analyses provided evidence that finerenone dose titration effectively controls serum potassium elev
- Author
- Dandung Ruskar
- Language
- EN